Acetylcysteine for Viral Hepatitis

Efficacy of NAC in Viral Hepatitis

NAC is suggested for acute liver failure regardless of etiology, including viral hepatitis, to improve morbidity and mortality (GRADE 2+ recommendation with strong agreement) 1, 3
A meta-analysis of adult patients with non-acetaminophen-related ALF showed improvements with NAC in overall survival (76% versus 59%, OR = 2.30, 95% CI 1.54–3.45, P <0.0001) 2
A meta-analysis of adult patients with non-acetaminophen-related ALF showed improvements with NAC in liver transplant-free survival (64% versus 26%, OR = 4.81, 95% CI 3.22–7.18, P < 0.0001) 2

It provides complex antioxidant and immunologic effects that help protect hepatocytes 4

NAC should be initiated early in the disease course for maximum benefit 4
The beneficial effects are more pronounced in patients with early-stage disease (grades I-II hepatic encephalopathy) 4
NAC is typically administered intravenously at varying doses in clinical studies 2
Treatment should be started as early as possible, as the interval between disease onset and treatment initiation is closely related to outcomes 4

Common adverse effects include nausea, vomiting, diarrhea or constipation 2
Less common side effects include skin rash (<5%) and transient bronchospasm (1-2%) 2

Viral hepatitis etiology affects prognosis: Hepatitis A has better transplant-free survival (approximately 50%) 5
Viral hepatitis etiology affects prognosis: Hepatitis B has poorer transplant-free survival (lower than 25%) 3
Early consultation with a liver transplantation center is recommended for patients with acute liver failure regardless of etiology 4

Assess severity using encephalopathy grade and laboratory parameters 3
Initiate NAC therapy early, particularly beneficial in grades I-II encephalopathy 3
Contact liver transplantation center for consultation, especially for hepatitis B cases 4
Monitor for treatment response and adverse effects 2
Consider liver transplantation evaluation for non-responders 5